F
Fu-Ming Zi
Researcher at Nanchang University
Publications - 5
Citations - 82
Fu-Ming Zi is an academic researcher from Nanchang University. The author has contributed to research in topics: Cathepsin K & Osteoclast. The author has an hindex of 3, co-authored 5 publications receiving 45 citations.
Papers
More filters
Journal ArticleDOI
Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.
TL;DR: H19 knockdown suppresses MM tumorigenesis via inhibiting BRD4-mediated cell proliferation through targeting miR-152-3p, implying that H19 is a promising biomarker and drug target for MM.
Journal ArticleDOI
The potential therapeutic benefit of resveratrol on Th17/Treg imbalance in immune thrombocytopenic purpura.
TL;DR: Mechanistic studies revealed that resveratrol reversed the Th17/Treg imbalance by a mechanism involving the suppression of the AhR pathway, which led to the impaired expression of ROR-γt and reduced secretion of IL-17A and IL-22, as well as enhanced expression of Foxp3 and augmented secretion ofIL-10.
Journal ArticleDOI
I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma.
TL;DR: I-BET151 inhibits osteoclast formation and inflammatory cytokine secretion by targetting BRD4-mediated RANKL-NF-κB signal pathway and BRD 4 inhibition might be beneficial for MM treatment.
Journal ArticleDOI
A transgene-encoded truncated human epidermal growth factor receptor for depletion of anti- B-cell maturation antigen CAR-T cells.
Qingming Wang,Feng He,Wenfeng He,Yan Huang,Junquan Zeng,Fu-Ming Zi,Jifu Zheng,Yan Fei,Jing Xu,Yuan Song,Xiaoyin Ye,Ruomei Lai,Longlong Ye,Bo Zhu +13 more
TL;DR: In this article, an anti-BCMA CAR-CAR-T-transduced T cells were evaluated for the functions including cytokine production, proliferation, cytotoxicity and in vivo tumor eradication.
Journal ArticleDOI
I‑BET151 inhibits osteoclastogenesis via the RANKL signaling pathway in RAW264.7 macrophages
TL;DR: I‑BET151 may significantly suppress the osteoclastogenesis of RAW264.7 cells via the RANKL signaling pathway and the inhibition was dose dependent.